Artificial Intelligence (AI) Model Development Framework for the Protection of State Borders, with a Focus on Analyzing Behavioral Patterns

Real-World Surveillance of FDA-Cleared Artificial Intelligence Models: Rationale and Logistics.

Artificial Intelligence: The Future of Maxillofacial Prognosis and Diagnosis?

Background: The topic of artificial Intelligence and its application in medicine has gained tremendous popularity, coinciding with advances in its technology. Breast cancer treatments vary, with surgery being one of them. In this review, we aim to evaluate artificial Intelligence’s ability to predict surgical outcomes, complications, and survival rates after breast cancer surgery by analyzing original research conducted over the last 5 years. Materials and Methods: A PubMed search was conducted by two authors from January 1, 2020, to April 13, 2025, using the keywords "Artificial Intelligence" and "Breast Surgery". After elimination, 14 of the 215 articles were full-text screened, and nine original articles were selected for inclusion in our review. Discussion: Artificial intelligence models and systems have had a significant impact on the medical field, and breast cancer surgery is no exception. Several original research studies have explored AI's ability to predict surgical outcomes and postoperative results. In this review, we focus on the postoperative aspects of breast cancer surgery and its application of artificial intelligence. Of the nine articles included in this paper, all reported multiple statistically significant results (p <0.05). Although no prospective research directly compares artificial intelligence with practicing physicians, artificial intelligence’s ability to accurately predict surgical outcomes, complications, and survival has shown higher accuracy and c-index than commonly used prediction methods, as reported in multiple studies. Conclusion: Artificial Intelligence can be a valuable asset in helping surgeons and medical doctors worldwide predict prognosis with improved systems and accuracy rates, even surpassing those of currently used conservative systems. There is a lack of information on PubMed regarding the comparison of these two aspects, particularly with larger sample sizes. More research should be conducted on this topic, particularly in comparing Artificial Intelligence systems and models with current systems and evaluation methods.

BackgroundAlthough capsule endoscopy (CE) is a crucial tool for diagnosing small bowel diseases, the need to process a vast number of images imposes a significant workload on physicians, leading to a high risk of missed diagnoses. This study aims to develop an artificial intelligence (AI) model and application based on convolutional neural networks that can automatically recognize various lesions in small bowel capsule endoscopy.MethodsThree small bowel capsule endoscopy datasets were used for AI model training, validation, and testing, encompassing 12 categories of images. The model’s performance was evaluated using metrics such as AUC, sensitivity, specificity, precision, accuracy, and F1 score to select the best model. A human-machine comparison experiment was conducted using the best model and endoscopists with varying levels of experience. Model interpretability was analyzed using Grad-CAM and SHAP techniques. Finally, a clinical application was developed based on the best model using PyQt5 technology.ResultsA total of 34,303 images were included in this study. The best model, MobileNetv3-large, achieved a weighted average sensitivity of 87.17%, specificity of 98.77%, and an AUC of 0.9897 across all categories. The application developed based on this model performed exceptionally well in comparison with endoscopists, achieving an accuracy of 87.17% and a processing speed of 75.04 frames per second, surpassing endoscopists of varying experience levels.ConclusionThe AI model and application developed based on convolutional neural networks can quickly and accurately identify 12 types of small bowel lesions. With its high sensitivity, this system can effectively assist physicians in interpreting small bowel capsule endoscopy images.Future studies will validate the AI system for video evaluations and real-world clinical integration.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12876-024-03482-7.

Statement of problem: Artificial intelligence (AI) applications are increasingly used in restorative process. But existing dentistry restoration effectiveness as well as growth and IA applications have not yet been systematically analyzed or documented. Purpose: The goal of such comprehensive evaluation is to discover & assess the abilities associated with artificial intelligence models in restorative dentistry for the analysis of caries as well as vertical tooth fracture, evaluate margins in preparing tooth, and analyze reconstructive failures. Methods: A systematic electronic review of 5 databases was carried out: PubMed/ MEDLINE, World of Science, EMBASE, Scopus and Cochrane. The investigation was carried out manually as well. Research using AI models was chosen on the basis of 4 criterion: dental caries diagnostics, diagnostics, vertical tooth fracture, tooth preparation recognition, & cause of failure of restoration. Both researchers rated the quality of the study for Critical Appraisal Checklist for Quasi-Experimental Studies (nonrandomized experimental studies). The 3rd author was asked for resolving the dispute. Results: 34 researches were made the part of this analysis: from which 29 contains artificial intelligence techniques including the diagnostics or treatment related to caries and its causes according to sensitivity models, 2 to diagnose vertical tooth fractures, 1 to prepare the teeth. Among the studied analysis, the accuracy of caries diagnosis in the AI models was tested from 76-88.3%, sensitivity from 73-90%, as well as specificity from 61.5-93%. In the study, the accuracy of predicted caries ranges from 83.6-97.1%. The performed research showed the accuracy of the analysis of a vertical tooth fracture from 88.3-95.7%. The study, which uses AI models to find a destination, had details with the range of 90.6-97.4%. Conclusions: AI models are a powerful tool for diagnosing caries as well as vertical tooth fractures, recognizing preparation margins and predicting restoration failures. But, the dental use of AI models continues to evolve. More research is needed to evaluate the clinical effectiveness of artificial intelligence models in restorative dentistry. Keyword: Artificial intelligence, restorative dentistry, vertical tooth fractures.

Quantum computing (QC) is not a futuristic notion in agriculture, though its full potential has yet to be realized. QC is an emerging field at the intersection of physics and computer science that holds immense potential to revolutionize various sectors, including agriculture production and artificial intelligence (AI) modeling. While QC is still in the early stages of development and practical applications within agriculture are not yet widespread, researchers are actively exploring its potential benefits in various agricultural domains, including crop optimization, livestock breeding, and environmental monitoring. QC harnesses the principles of quantum mechanics to perform computations using quantum bits or qubits, which can exist in multiple states simultaneously. Unlike classical computers, which rely on binary bits representing 0 or 1, quantum computers exploit phenomena such as superposition and entanglement to process information in parallel, potentially offering exponential speedup for certain types of problems. In agriculture production, particularly in animal science, QC offers promising avenues for optimizing processes and enhancing productivity. Quantum algorithms can analyze vast amounts of genomic data to improve breeding programs, leading to the development of more resilient and productive livestock breeds. Furthermore, QC can facilitate precision farming techniques by modeling complex environmental factors and animal behavior to optimize feeding strategies, disease management, and overall farm management practices. Moreover, QC can significantly benefit AI modeling by accelerating computations and enabling more efficient training of AI models. Quantum algorithms can enhance the performance of AI algorithms in various tasks, including pattern recognition, natural language processing, and predictive analytics. By leveraging quantum-enhanced optimization algorithms, AI models can achieve better convergence and accuracy, leading to more effective decision-making and problem-solving capabilities. While hybrid intelligent models also represent a novel frontier in agriculture, QC has the potential to expedite the merging of mechanistic and AI modeling paradigms, facilitating a more holistic understanding of complex systems in agriculture and beyond. By integrating mechanistic models, which describe the underlying physical processes, with AI models, which learn patterns from data, quantum computing can enable comprehensive simulations and predictions of agricultural systems. This fusion of modeling paradigms can lead to more accurate and robust predictions of crop yields, livestock performance, and environmental impacts, facilitating informed decision-making for farmers and policymakers. The application of QC in agriculture, however, requires interdisciplinary collaborations between physicists, computer scientists, agronomists/animal scientists, and AI researchers. These collaborations can drive the development of quantum algorithms tailored to agricultural applications, the integration of quantum-enhanced AI techniques into existing modeling frameworks, and the deployment of QC resources in real-world agricultural systems. Ultimately, harnessing the power of QC holds the potential to revolutionize agriculture production practices, including regenerative agriculture, and advance AI modeling capabilities, paving the way for a more sustainable and efficient agricultural industry.

Aim: The majority of machine learning (ML) models in healthcare are built on retrospective data, much of which is collected without explicit patient consent for use in artificial intelligence (AI) and ML applications. The primary aim of this study was to evaluate whether clinicians and scientific researchers themselves consent to provide their own data for the training of ML models. Materials and Methods: This survey was conducted through an anonymous online survey, utilizing platforms such as Telegram, LinkedIn, and Viber. The target audience comprised specific international groups, primarily Russian, German, and English-speaking, of clinicians and scientific researchers. These participants ranged in their levels of expertise and experience, from beginners to veterans. The survey centered on a singular, pivotal question: “Do You Consent to the Use of Your Biological and Private Data for Training Machine Learning and AI Models?” Respondents had the option to choose from three responses: “Yes” and “No”. Results: The survey was conducted in January 2024. A total of 119 unique and verified individuals participated in the survey. The results revealed that only 50% of respondents (63 persons) expressed consent to provide their own data for the training of ML and AI models. Conclusion: In the development of ML and AI models, particularly open-source ones, it is crucial to ascertain whether participants are willing to provide their private data. While ML algorithms can transform the nature of data, it is important to remember that the primary owner of this data is the individual. Our findings show that in 50% of the cases, even participants from scientific research and clinical backgrounds – individuals typically accountable for ensuring data quality in AI and ML model development – do not consent to the use of their data in AI and ML settings. This highlights the need for more stringent consent processes and ethical considerations in the utilization of personal data in AI and ML research.

The secondary use of health data for training Artificial Intelligence (AI) models holds immense potential for advancing medical research and healthcare delivery. However, ensuring patient consent for such utilization is paramount to uphold ethical standards and data privacy. Patient informed consent means patients are fully informed about how their data will be collected, used, and protected, and they voluntarily agree to allow their data to be used for AI models. In addition to formal consent frameworks, establishing a social license is critical to foster public trust and societal acceptance for the secondary use of health data in AI systems. This study examines patient consent practices in this domain. In this scoping review, we searched Web of Science, PubMed, and Scopus. We included studies in English that addressed the core issues of interest, namely, privacy, security, legal, and ethical issues related to the secondary use of health data in AI models. Articles not addressing the core issues, as well as systematic reviews, meta-analyses, books, letters, conference abstracts, and study protocols were excluded. Two authors independently screened titles, abstracts, and full texts, resolving disagreements with a third author. Data was extracted using a data extraction form. After screening 774 articles, a total of 38 articles were ultimately included in the review. Across these studies, a total of 178 barriers and 193 facilitators were identified. We consolidated similar codes and extracted 65 barriers and 101 facilitators, which we then categorized into four themes: "Structure," "People," "Physical system," and "Task." We identified notable emphasis on "Legal and Ethical Challenges" and "Interoperability and Data Governance." Key barriers included concerns over privacy and security breaches, inadequacies in informed consent processes, and unauthorized data sharing. Critical facilitators included enhancing patient consent procedures, improving data privacy through anonymization, and promoting ethical standards for data usage. Our study underscores the complexity of patient consent for the secondary use of health data in AI models, highlighting significant barriers and facilitators within legal, ethical, and technological domains. We recommend the development of specific guidelines and actionable strategies for policymakers, practitioners, and researchers to improve informed consent, ensuring privacy, trust, and ethical use of data, thereby facilitating the responsible advancement of AI in healthcare.

This study evaluated if medical doctors could identify more hemorrhage events during chart review in a clinical setting when assisted by an artificial intelligence (AI) model and medical doctors' perception of using the AI model. To develop the AI model, sentences from 900 electronic health records were labeled as positive or negative for hemorrhage and categorized into one of 12 anatomical locations. The AI model was evaluated on a test cohort consisting of 566 admissions. Using eye-tracking technology, we investigated medical doctors' reading workflow during manual chart review. Moreover, we performed a clinical use study where medical doctors read two admissions with and without AI assistance to evaluate performance when using and perception of using the AI model. The AI model had a sensitivity of 93.7% and a specificity of 98.1% on the test cohort. In the use studies, we found that medical doctors missed more than 33% of relevant sentences when doing chart review without AI assistance. Hemorrhage events described in paragraphs were more often overlooked compared with bullet-pointed hemorrhage mentions. With AI-assisted chart review, medical doctors identified 48 and 49 percentage points more hemorrhage events than without assistance in two admissions, and they were generally positive toward using the AI model as a supporting tool. Medical doctors identified more hemorrhage events with AI-assisted chart review and they were generally positive toward using the AI model.

To develop an artificial intelligence (AI) model able to perform both segmentation of hand joint ultrasound images for osteophytes, bone, and synovium and perform osteophyte severity scoring following the EULAR-OMERACT grading system (EOGS) for hand osteoarthritis (OA). One hundred sixty patients with pain or reduced function of the hands were included. Ultrasound images of the metacarpophalangeal (MCP), proximal interphalangeal (PIP), distal interphalangeal (DIP), and first carpometacarpal (CMC1) joints were then manually segmented for bone, synovium and osteophytes and scored from 0 to 3 according to the EOGS for OA. Data was divided into a training, validation, and test set. The AI model was trained on the training data to perform bone, synovium, and osteophyte identification on the images. Based on the manually performed image segmentation, an AI was trained to classify the severity of osteophytes according to EOGS from 0 to 3. Percent Exact Agreement (PEA) and Percent Close Agreement (PCA) were assessed on individual joints and overall. PCA allows a difference of one EOGS grade between doctor assessment and AI. A total of 4615 ultrasound images were used for AI development and testing. The developed AI model scored on the test set for the MCP joints a PEA of 76% and PCA of 97%; for PIP, a PEA of 70% and PCA of 97%; for DIP, a PEA of 59% and PCA of 94%, and CMC a PEA of 50% and PCA of 82%. Combining all joints, we found a PEA between AI and doctor assessments of 68% and a PCA of 95%. The developed AI model can perform joint ultrasound image segmentation and severity scoring of osteophytes, according to the EOGS. As proof of concept, this first version of the AI model is successful, as the agreement performance is slightly higher than previously found agreements between experts when assessing osteophytes on hand OA ultrasound images. The segmentation of the image makes the AI explainable to the doctor, who can immediately see why the AI applies a given score. Future validation in hand OA cohorts is necessary though.

Solar energy-based technologies have developed rapidly in recent years, however, the inability to appropriately estimate solar energy resources is still a major drawback for these technologies. In this study, eight different artificial intelligence (AI) models namely; convolutional neural network (CNN), artificial neural network (ANN), long short-term memory recurrent model (LSTM), eXtreme gradient boost algorithm (XG Boost), multiple linear regression (MLR), polynomial regression (PLR), decision tree regression (DTR), and random forest regression (RFR) are designed and compared for solar irradiance prediction. Additionally, two hybrid deep neural network models (ANN-CNN and CNN-LSTM-ANN) are developed in this study for the same task. This study is novel as each of the AI models developed was used to estimate solar irradiance considering different timesteps (hourly, every minute, and daily average). Also, different solar irradiance datasets (from six countries in Africa) measured with various instruments were used to train/test the AI models. With the aim to check if there is a universal AI model for solar irradiance estimation in developing countries, the results of this study show that various AI models are suitable for different solar irradiance estimation tasks. However, XG boost has a consistently high performance for all the case studies and is the best model for 10 of the 13 case studies considered in this paper. The result of this study also shows that the prediction of hourly solar irradiance is more accurate for the models when compared to daily average and minutes timestep. The specific performance of each model for all the case studies is explicated in the paper.

AI is one of the biggest megatrends towards the 4th industrial revolution. Although these technologies promise business sustainability as well as product and process quality, it seems that the ever-changing market demands, the complexity of technologies and fair concerns about privacy, impede broad application and reuse of Artificial Intelligence (AI) models across the industry. To break the entry barriers for these technologies and unleash its full potential, the knowlEdge project will develop a new generation of AI methods, systems, and data management infrastructure. Subsequently, as part of the knowlEdge project we propose several major innovations in the areas of data management, data analytics and knowledge management including (i) a set of AI services that allows the usage of edge deployments as computational and live data infrastructure as well as a continuous learning execution pipeline on the edge, (ii) a digital twin of the shop-floor able to test AI models, (iii) a data management framework deployed along the edge-to-cloud continuum ensuring data quality, privacy and confidentiality, (iv) Human-AI Collaboration and Domain Knowledge Fusion tools for domain experts to inject their experience into the system, (v) a set of standardisation mechanisms for the exchange of trained AI models from one context to another, and (vi) a knowledge marketplace platform to distribute and interchange trained AI models. In this paper, we present a short overview of the EU Project knowlEdge –Towards Artificial Intelligence powered manufacturing services, processes, and products in an edge-to-cloud-knowledge continuum for humans [in-the-loop], which is funded by the Horizon 2020 (H2020) Framework Programme of the European Commission under Grant Agreement 957331. Our overview includes a description of the project’s main concept and methodology as well as the envisioned innovations.

High-risk breast lesions (HRLs) are associated with future risk of breast cancer. Considering the pathological subtypes, malignancy upgrade rate differs according to each subtype and depends on various factors such as clinical and radiological features and biopsy method. Using artificial intelligence and machine learning models in breast imaging, evaluations can be made in terms of risk estimation in different research areas. This study aimed to develop a machine learning model to distinguish HRL cases requiring surgical excision from lesions with a low risk of accompanying malignancy. A total of 94 patients who were diagnosed with HRL by image-guided biopsy between January 2008 and March 2020 were included in the study. A structured database was created with clinical and radiological characteristics and histopathological results. A machine learning prediction model was created to make binary classifications of lesions as malignant or benign. Random forest, decision tree, K-nearest neighbors, logistic regression, support vector machine (SVM), and multilayer perceptron machine learning algorithms were used. Among these algorithms, SVM was the most successful. The estimations of malignancy for each case detected by artificial intelligence were combined and statistical analyses were performed. Considering all cases, the malignancy upgrade rate was 24.5%. A significant association was observed between malignancy upgrade rate and lesion size (P = 0.004), presence of mammography findings (P = 0.022), and breast imaging-reporting and data system category (P = 0.001). A statistically significant association was also found between the artificial intelligence prediction model and malignancy upgrade rate (P < 0.001). With the SVM model, an 84% accuracy and 0.786 area-underthe- curve score were obtained in classifying the data as benign or malignant. Our artificial intelligence model (SVM) can predict HRLs that can be followed up with a lower risk of accompanying malignancy. Unnecessary surgeries can be reduced, or second line vacuum excisions can be performed in HRLs, which are mostly benign, by evaluating on a case-by-case basis, in line with radiology-pathology compatibility and by using an artificial intelligence model.

Artificial intelligence is used in predicting the clinical outcomes before minimally invasive treatments for benign prostatic hyperplasia, to address the insufficient reliability despite multiple assessment parameters, such as flow rates and symptom scores. Various models of artificial intelligence and its contemporary applications in benign prostatic hyperplasia are reviewed and discussed. A search strategy adapted to identify and review the literature on the application of artificial intelligence with a dedicated search string with the following keywords: “Machine Learning,” “Artificial Intelligence,” AND “Benign Prostate Enlargement” OR “BPH” OR “Benign Prostatic Hyperplasia” was included and categorized. Review articles, editorial comments, and non-urologic studies were excluded. In the present review, 1600 patients were included from 4 studies that used different classifiers such as fuzzy systems, computer-based vision systems, and clinical data mining to study the applications of artificial intelligence in diagnoses and severity prediction and determine clinical factors responsible for treatment response in benign prostatic hyperplasia. The accuracy to correctly diagnose benign prostatic hyperplasia by Fuzzy systems was 90%, while that of computer-based vision system was 96.3%. Data mining achieved sensitivity and specificity of 70% and 50%, respectively, in correctly predicting the clinical response to medical treatment in benign prostatic hyperplasia. Artificial intelligence is gaining attraction in urology, with the potential to improve diagnostics and patient care. The results of artificial intelligence-based applications in benign prostatic hyperplasia are promising but lack generalizability of results. However, in the future, we will see a shift in the clinical paradigm as artificial intelligence applications will find their place in the guidelines and revolutionize the decision-making process.Keywords: Artificial intelligence; deep learning; machine learning; benign prostate enlargement; benign prostatic hyperplasia.

Background Despite echocardiography being essential for cardiac assessment, a point-of-care tool for rapid left ventricular ejection fraction (LVEF) evaluation is lacking in current clinical practice, highlighting the need for a widescale, easily deployable method to assess LV function. Purpose To develop and validate two artificial intelligence (AI) models that accurately detect reduced LVEF on a single 12-lead ECG using a smartphone, facilitating early identification of patients at risk for heart failure who may benefit from more detailed echocardiographic evaluation. Methods A large collection of ECGs and transthoracic echocardiograms (TTEs) was sourced from our hospital data vault from 2011 to 2021. ECGs were paired to TTEs within a 24h time window and the resulting pairs were randomly assigned to the model development dataset (50%) and validation dataset (50%). Two distinct AI-ECG models were developed: one to detect LVEF≤40% and another for LVEF&amp;lt;50%, derived from the ESC definition of heart failure. Both AI-ECG models were paired with smartphone based ECG digitization technology. Key performance metrics include area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1-score. Results A total of 1,205,370 ECGs (198,274 patients) and 291,433 TTEs (105,849 patients) were collected and paired, resulting in 109,809 ECG-TTE pairs (56,236 patients). The validation dataset consisted of 25,510 distinct TTE-ECG pairs (25,510 patients). Prevalence of LVEF≤40% and LVEF&amp;lt;50% was 5.4% and 7.9% respectively. The LVEF≤40% model demonstrated an AUC of 0.963 (95% CI: 0.959-0.966), sensitivity 0.924 (95% CI: 0.91-0.937), specificity 0.887 (95% CI: 0.883-0.891), and F1-score of 0.474 (95% CI: 0.457-0.490). PPV and NPV were 0.318 (95% CI: 0.304-0.333) and 0.995 (95% CI: 0.994-0.996) respectively. Performance of the LVEF &amp;lt;50% model shows an AUC of 0.952 (95% CI: 0.947-0.956), with a slightly lower sensitivity of 0.899 (95% CI: 0.886-0.912), specificity of 0.875 (95% CI: 0.871-0.879), PPV of 0.382 (95% CI: 0.368-0.395), NPV of 0.99 (95% CI: 0.989-0.992), and F1-score of 0.536 (0.521-0.55). Conclusion The AI models exhibit the ability to identify reduced LVEF from standard 12-lead ECGs using a smartphone. Results suggest potential clinical utility as a preliminary screening tool to select patients for confirmatory echocardiography. This AI application could potentially offer a timely and cost-effective method for identifying patients at risk for future development of heart failure.